중재적 폐 솔루션 시장 보고서(2025년)
Interventional Lung Solutions Global Market Report 2025
상품코드 : 1760572
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

중재적 폐 솔루션 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 원격 의료 및 원격 모니터링의 확산, 개인화 의료에 대한 관심 증가, 로봇 보조 수술의 인기 상승, 최소 침습적 절차의 확산, 정밀 의료에 대한 관심 증가 등에 기인합니다. 이 기간 동안 예상되는 주요 동향으로는 첨단 폐암 치료법 개발, 기관지 내시경 시스템에 인공 지능 통합, 중재적 폐학 및 종양 치료의 통합, 폐 질환 관리를 위한 디지털 플랫폼 통합, 폐 재생 치료의 혁신 등이 있습니다.

호흡기 질환의 유병률이 증가함에 따라 향후 몇 년 동안 중재적 폐 솔루션 시장의 확장이 크게 촉진될 것으로 예상됩니다. 호흡기 질환은 폐와 기도에 영향을 미쳐 호흡을 방해하고 정상적인 호흡 기능을 방해하는 다양한 의료적 상태를 포함합니다. 호흡기 질환의 증가 는 주로 대기 오염 수준 증가로 인해 유해한 공기 중 입자 및 자극물질에 장기간 노출되는 것이 주요 원인으로 지목됩니다. 폐 중재적 솔루션은 만성 폐 질환 환자의 폐 기능을 개선하고 증상을 완화하는 최소 침습적 절차를 제공함으로써 이러한 질환을 관리하는 데 도움을 줍니다. 예를 들어, 2023년 11월, 미국 정부 기관인 질병통제예방센터(CDC)는 2022년 미국에서 약 8,331건의 결핵 사례가 보고되어 전년도에 비해 5.9% 증가했다고 밝혔습니다. 호흡기 질환의 유병률이 증가하면서 중재적 폐 솔루션 시장의 성장이 촉진되고 있습니다.

중재적 폐 솔루션 시장의 주요 업체들은 폐암 진단의 정확성을 높이고, 최소 침습적 시술을 가능하게 하며, 첨단 내비게이션 및 생검 기능을 통해 환자의 치료 결과를 개선하기 위해 Ion Endoluminal System과 같은 최신기술의 개발에 주력하고 있습니다. Ion Endoluminal System은 최소 침습적 폐 시술을 위해 설계된 로봇 보조 플랫폼으로, 작거나 접근이 어려운 폐 결절에 접근할 수 있도록 정확한 기도 내비게이션을 가능하게 합니다. 예를 들어, 2024년 4월 미국 기반 비영리 기관인 H. Lee Moffitt 암 센터 및 연구소 재단(H. Lee Moffitt Cancer Center and Research Institute Foundation Inc.)은 고급 광섬유 기술과 최소 침습적 카테터 시스템을 결합한 새로운 Ion Robotic Bronchoscopy 플랫폼을 출시했습니다. 이 기술은 광섬유와 시장에서 가장 작은 카테터를 활용해 폐의 모든 부위에 접근할 수 있습니다. 이 시스템은 180° 회전이 가능한 초박형, 기동성이 뛰어난 카테터, 통합된 실시간 영상, 형상 감지 기술을 특징으로 하며, 접근이 어려운 말초 폐 결절의 정밀한 탐색 및 생검을 가능하게 합니다. 이 시스템은 조직 샘플링에 전례 없는 안정성과 정확성을 제공하여 의사가 18개 폐 부위 모두에 접근할 수 있게 함으로써, 초기 폐암의 발견률을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Interventional lung solutions refer to minimally invasive procedures and technologies designed to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions typically include interventions such as bronchoscopy, endobronchial valves, and image-guided therapies, all aimed at improving lung function and enhancing patient outcomes.

The main types of interventional lung solutions include bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other related devices. Bronchoscopes are medical instruments used to visualize and examine the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies associated with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The procedures involved include bronchoscopy, thoracoscopy, pleuroscopy, and others. These solutions are applied in various medical fields such as lung cancer treatment, COPD management, and sleep apnea treatment, and are used by a variety of end-users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.

The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides interventional lung solutions market statistics, including the interventional lung solutions industry's global market size, regional shares, competitors with the interventional lung solutions market share, detailed interventional lung solutions market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions market. This interventional lung solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing number of smokers worldwide, rising air pollution levels, increasing healthcare awareness, and the growing number of lung cancer cases.

The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing adoption of telemedicine and remote monitoring, an increasing focus on personalized medicine, the rising popularity of robotic-assisted surgery, the growing adoption of minimally invasive procedures, and an increasing focus on precision medicine. Major trends expected during this period include the development of advanced lung cancer interventions, the integration of artificial intelligence in bronchoscopy systems, the merging of interventional pulmonology with oncology treatments, the integration of digital platforms for lung disease management, and innovations in lung regeneration therapies.

The growing prevalence of respiratory diseases is expected to significantly drive the expansion of the interventional lung solutions market in the coming years. Respiratory diseases encompass a range of medical conditions that affect the lungs and airways, impairing breathing and disrupting normal respiratory function. The increase in respiratory diseases is largely attributed to rising levels of air pollution, which contribute to prolonged exposure to harmful airborne particles and irritants. Interventional lung solutions assist in managing these diseases by providing minimally invasive procedures that improve lung function and alleviate symptoms in patients with chronic pulmonary conditions. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported approximately 8,331 tuberculosis cases in the United States in 2022, marking a 5.9% increase from the previous year. This growing prevalence of respiratory diseases is driving the growth of the interventional lung solutions market.

Key players in the interventional lung solutions market are focusing on the development of cutting-edge technologies, such as the Ion Endoluminal System, to enhance the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and improve patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to access small or difficult-to-reach lung nodules. For example, in April 2024, the H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit organization, launched a new Ion Robotic Bronchoscopy platform to enhance their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology employs fiber optics and the smallest catheter available on the market to access all areas of the lungs. It features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of peripheral lung nodules that are difficult to reach. This system offers unprecedented stability and accuracy for tissue sampling, enabling physicians to reach all 18 lung segments, thus improving the detection of early-stage lung cancer.

In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed amount. This acquisition is aimed at strengthening Stryker's interventional endovascular portfolio by adding innovative thrombolytic-free solutions for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. Inari Medical Inc., based in the US, specializes in providing interventional solutions for pulmonary conditions, with a particular focus on treating pulmonary embolism (PE).

Major players in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., The Lung Docs Inc., EndoMed Systems GmbH.

North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional lung solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional lung solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Lung Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional lung solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for interventional lung solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional lung solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Interventional Lung Solutions Market Characteristics

3. Interventional Lung Solutions Market Trends And Strategies

4. Interventional Lung Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Lung Solutions Growth Analysis And Strategic Analysis Framework

6. Interventional Lung Solutions Market Segmentation

7. Interventional Lung Solutions Market Regional And Country Analysis

8. Asia-Pacific Interventional Lung Solutions Market

9. China Interventional Lung Solutions Market

10. India Interventional Lung Solutions Market

11. Japan Interventional Lung Solutions Market

12. Australia Interventional Lung Solutions Market

13. Indonesia Interventional Lung Solutions Market

14. South Korea Interventional Lung Solutions Market

15. Western Europe Interventional Lung Solutions Market

16. UK Interventional Lung Solutions Market

17. Germany Interventional Lung Solutions Market

18. France Interventional Lung Solutions Market

19. Italy Interventional Lung Solutions Market

20. Spain Interventional Lung Solutions Market

21. Eastern Europe Interventional Lung Solutions Market

22. Russia Interventional Lung Solutions Market

23. North America Interventional Lung Solutions Market

24. USA Interventional Lung Solutions Market

25. Canada Interventional Lung Solutions Market

26. South America Interventional Lung Solutions Market

27. Brazil Interventional Lung Solutions Market

28. Middle East Interventional Lung Solutions Market

29. Africa Interventional Lung Solutions Market

30. Interventional Lung Solutions Market Competitive Landscape And Company Profiles

31. Interventional Lung Solutions Market Other Major And Innovative Companies

32. Global Interventional Lung Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Lung Solutions Market

34. Recent Developments In The Interventional Lung Solutions Market

35. Interventional Lung Solutions Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기